Kingsview Wealth Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Kingsview Wealth Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-12,850	Closed	-$66K	–	501
2019 Q2	$66K	Sell	12,850 -6,300	-33%	-$28.3K	0.01%	404
2019 Q1	$69K	Buy	+19,150	New	+$83K	0.01%	439

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Kingsview Wealth Management's PETX Position: Q3 2019 in Review

Kingsview Wealth Management sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 12,850 shares — an estimated $66K sold.

Kingsview Wealth Management first reported a position in PETX in Q1 2019 and held it in 2 quarters. The position peaked at $69K in Q1 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Kingsview Wealth Management reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Kingsview Wealth Management sold 12,850 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $66K.
Kingsview Wealth Management first reported a position in Aratana Therapeutics, Inc. in Q1 2019 and held it in 2 quarters.
Kingsview Wealth Management's Aratana Therapeutics, Inc. position peaked at $69K in Q1 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Kingsview Wealth Management's 13F filing for Q3 2019, filed 29 Jan 2020.